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Introduction
Chronic rhinosinusitis (CRS) is defined as inflamma-
tion of the nose and the paranasal sinuses characterised by
two or more symptoms, one of which should be either nasal
blockage/obstruction/congestion or nasal discharge (anterior,
posterior nasal drip) + facial pain/pressure + reduction or
loss of smell sensation of smell and either endoscopic signs
of polyps and/or mucopurulent discharge primarily from the
middle meatus and/or edema/mucosal obstruction primarily
in middle meatus, and/or computerized tomography (CT)
changes showing mucosal changes within the ostiomeatal
complex and/or sinuses from more than 12 weeks 
1.
It is an increasingly common cause of patients visits to
physicians and the principal diagnosis in nearly 2% of them 
2.
The prevalence of rhinosinusitis is estimated to be 14% of the
global population 
3. The location and extent of different rhino-
sinusitis pathological conditions imply a detailed knowledge
of anatomic organization of paranasal sinuses, and the first and
foremost of ethmoid sinuses. The structures of the lateral nasal
wall and paranasal sinuses fall into two anatomically and
physiologically distinct categories: the anterior and posterior
ethmoid complex. The basal lamella of the middle turbinate is
the distinct separation between the two ethmoid complexes.
The ostiomeatal complex (OMC) is a functional entity of the
anterior ethmoidal complex that represents the final common
pathway for drainage and ventilation of the frontal, maxillary
and anterior ethmoid cells. The sphenoethmoidal recess is a
functional entity of the posterior ethmoid complex that repre-
sents the final common pathway for drainage and ventilation
of the sphenoid and posterior ethmoid cells. Three clinical en-
tities of CRS may be defined: chronic rhinitis, localized si-
nusitis and diffuse rhinosinusitis 
2.
Chronic rhinosinusitis is a multifactorial disease. Pre-
disposing factors can be divided into: local host factors, gen-
eral host factors and environmental or non-host factors 
1, 4.
Local host factors
Anatomic variations
Certain anatomic variations such as concha bullosa, na-
sal septal deviation and a displaced uncinate process have
been suggested as potential risk factors for developing
CRS 
1. The ethmoid sinus area (OMC) is believed to be a
major focus for the initiation of CRS 
4. The overall incidence
of inflammatory disease in OMC in symptomatic patients is
not different between those with and without concha bullosa.
However, there were many cases in which an abnormally
large middle turbinate appeared to obstruct OMC causing
secondary infection of the ethmoid, frontal and maxillary si-
nuses 
5. Sinus disease usually starts in the middle of nasal
meatus. Many conditions cause narrow or blocking of this
space resulting in retention of nasal secret and poor ventila-
tion. Sometimes very localized areas of contact of opposing
mucosal surfaces in these key areas of the anterior ethmoid
may lead to such a blockage, which in turn may alter nasal
function. If opposing mucosal areas come into intense con-
tact, their ciliary beating either stops or is impeded. The mu-
cus between these contacting areas is no longer transported.
This stasis provides an ideal condition for viral and bacterial
infection 
6. Although OMC is important in CRS, it is not the
underlying cause of the disease, and the importance of anat-
omic anomalies is often overestimated 
1, 4. Bhattacharyya 
7
has shown that maxillary sinus retention cysts do not reflect
persistent obstructive pathology on OMC, and are not asso-
ciated with potentially obstructive anatomic sinus variations.
Some studies suggest that concha bullosa may have a role in
CRS etiology, while some other suggest that there is no sta-
tistically significant relationship between the presence of a
unilateral or dominant concha bullosa and OMC, maxillary
and frontal sinus disease 
8, 9.
Chronic rhinosinusitis is an important clinical problem
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are very different from those in adults 
10. Kim at al. 
10 have
found that agger nasi cell is the most common anatomical
variation, followed by septal deviation, Haller cell, concha
bullosa, paradoxical middle turbinate, and Onodi cell. How-
ever, they have not found any significant relationship be-
tween CRS and anatomic variations. Adenoid vegetation
may cause nasal discharge that is not necessarily due to si-
nusitis. We could not find any supportive data for the state-
ment that “the greater the adenoid tissue, the more extensive
sinusitis” 
11.
General host factors
General host factors, such as genetic factors and immu-
nodeficiency, significantly increase the potential for the de-
velopment of CRS 
4.
Genetic factors
The role of genetic factors in some disorders that pre-
dispose to CRS is well defined, for example, cystic fibrosis
(CF), Young’s syndrome, primary ciliary dyskinesia, con-
genital immunodeficiency syndrome and MUC8 mucin gene
up-regulation. Kennedy 
4 mentioned that mutation of the CF
genes were significantly more common in patients with CRS
than in controls (7% vs. 2%), even after exclusion of a pa-
tient with undiagnosed CF. Although the carrier frequency
for CF ranges from 3−4% in the general population, the
prevalence of mutation in the CF transmembrane conduc-
tance regulator (CFTR) among the patients with CRS is un-
known 
1, 12, 13. These observations suggest that mutations of
genes responsible for CF may be associated with the devel-
opment of CRS 
1, 4. Chronic rhinosinusitis is a common de-
bilitating disease principally affecting sinonasal epithelial
function with a resultant diminution of mucociliary transport.
Although primary ciliary dyskinesia is commonly associated
with CRS, little is known about how this process affects the
sinonasal epithelial ciliated cells 
14.
Mucus secretion by both goblet cells and submucosal
gland cells is one of the most important defense mechanisms
in the nose and paranasal sinuses. However, excessive mucus
production characterizes upper airway diseases such as CRS
and allergic rhinitis. The major macromolecular constituents
of mucus are mucins, which are highly glycosylated proteins.
The amount of mucus produced in the human airway is
mainly balanced by the rate of production and clearance. A
violation of this balance of mucus production and clearance
may lead to many clinical problems. Mucus hypersecretion is
a common feature in CRS. Heung-Man et al. 
15 examined
expression of MUC8 messenger RNA (mRNA) and protein
in mucosae of patients with CRS and control subjects and
found an increased synthesis of MUC8 mRNA and protein in
the CRS specimens than in the normal sinus mucosae.
Immunocompromised state
Dysfunction of the immune system may occur during
the life and present in CRS. T-lymphocytes showed abnor-
mal proliferation in response to antigen recall. Low immu-
noglobulin (Ig) G, A and M titres were found in 18, 17 and
5% of the patients with refractory sinusitis, respectively 
1.
The most common immune deficiency associated with CRS
is an IgG subclass deficiency 
4. It was found that CRS was
present in more than half of HIV-positive population 
1.
Environmental and other non-host factors
Substantial evidences support the premise that envi-
ronmental and other non-host-related factors, such as air
pollution, smoke, allergens, viruses, fungi and bacteria, pre-
dispose individuals to CRS 
4.
Air pollution
Cigarette smoking was associated with a higher preva-
lence of CRS. In spite of in vitro data of the toxic effects of
pollutans on respiratory epithelium, there is no convincing
evidence of the etiologic role of toxins such as ozone in
CRS 
1, 16.
Aspirin intolerance
Samter’s triad is a combination of CRS with nasal pol-
yps, asthma and aspirin sensitivity. It is though that aspirin
and other nonsteroidal anti-inflammatory drugs (NSAIDs)
inhibit the activity of the enzyme cyclooxygenase-1 (COX-1)
in the arachidonic acid metabolism pathway, resulting in an
increase in the activity of the enzyme 5-lipooxygenase in the
affected patients. The products of the 5-lipooxygenase path-
way include the leukotrienes (LTC4, LTD4 and LTE4),
which are potent inflammatory mediators that can induce
mucus secretion, bronchoconstriction of the airway, and
edema of the nasal mucosa and attract eosinophils into the
airway 
17. Aspirin intolerant patients show elevated basal
levels of leukotrienes and reduced basal levels of prostaglan-
din E2 
18. Patients with Samter’s triade generally tend to
have more severe symptoms of CRS with nasal polyposis
and asthma than do patients without the triad. Nasal polypo-
sis was found in the majority of cases, often recurrent after
previous surgery 
17, 18.
Allergy and asthma
Review articles on CRS have suggested that atopy pre-
disposes to its development, tempting to speculate that aller-
gic inflammation in the nose predisposes the atopic individ-
ual to the development of CRS 
1. It has been postulated that
swelling of the nasal mucosa in allergic rhinitis at the site of
the sinus ostia may compromise ventilation and even ob-
struct them, leading to mucus retention and infection. Nu-
merous of studies report that markers of atopy are more
prevalent in population with CRS 
1, 19. However, the role of
allergy in CRS is questioned by other epidemiologic studies
showing no increase in the incidence of infectious rhinosinu-
sitis during the pollen season in pollen sensitized patients 
1.
The association between asthma and CRS has long been
established. In general, CRS in patients with asthma tends to
be more severe and refractory to conventional medical man-
agement than it is in patients without asthma 
19. Multiple
theories have been proposed to explain the association be-
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material is aspirated into the lower airways, where it irritates
the epithelium and exacerbates asthma 
1. According to an-
other theory, which involves a proposed sinonasal-bronchial
reflex, the bronchoconstriction that asthmatic patients expe-
rience is caused by CRS-induced vagal stimulation. Support
for this mechanism is provided by the fact that many patients
with asthma report an increase in asthma symptoms during
acute episodes of CRS 
19. In patients with both asthma and
CRS, respiratory epithelial cells produce a range of cytokines
(interleukins: IL-3, IL-4, IL-5, IL-13, eotaxin and granulo-
cyte-macrophage colony-stimulating factor) that could affect
the recruitment and activation of inflammatory leukocytes.
The resultant increase in inflammatory mediators (histamine,
thromboxane and leukotrienes) leads to the increased vascu-
lar permeability, mucus hypersecretion, ciliary impairment
and mucosal edema, which can obstruct the sinus ostia and
create an optimal environment for bacterial overgrowth 
19.
Fungal infection
The role of fungi in the causation of CRS is still con-
troversal. The rate of fungal infection in the nasal passage
by culture, histopathology, or polymerase chain reaction
(PCR) is reported to be in the range of 26.7−93% in
CRS 
20. Allergic fungal rhinosinusitis (AFR) is a noninva-
sive IgE-mediated form, accounting for 5−10% of all CRS
cases, by conventional criteria 
1, 21. By the Mayo Clinic
criteria, chronic eosinophilic rhinosinusitis is present in
nearly 100% of patients with rhinosinusitis or nasal poly-
posis 
21. The clinical features of AFR include refractory
chronic sinusitis, presence of allergic mucin (containing
fungal hyphae and sheets of eosinophils), tissue damage
showing marked eosinophilia, positive skin test for allergy
to the fungus found in the mucin, and the absence of any
kind of invasive fungal involvement in the tissues 
21. Fun-
gal rhinosinusitis tends to affect a relatively young popula-
tion of individuals who are generally atopic and recognized
as asthmatic 
21, 22. Six steps was found in the pathogenesis
of AFR: the host becomes sensitized to fungal antigens;
fungal spores become trapped in nasal or sinus mucus and
germinate into viable hyphae; in seasonal and perennial al-
lergic rhinitis, the profile of T-cell cytokines in nasal tissue
fits the classic Th2 profile, with the production of cytokines
IL-3, IL-4, IL-5, IL-13, and granulocyte-macrophage col-
ony-stimulating factor. These cytokines give rise to IgE
production with local mast cell degranulation and accumu-
lation of eosinophils and allergen-specific Th2 cells in al-
lergic nasal tissue; eosinophils attack fungal hyphae and
degranulate; the eosinophilic inflammatory process releases
multiple cytokines and growth factors, which may contrib-
ute to airway remodeling and nasal polyp formation. The
local inflammatory response probably also triggers a sys-
temic response with release of eosinophil precursors from
the bone marrow 
21−23. Some studies have shown that nasal
polyps contain increased numbers of IL-5-producing T-
lymphocytes and CD34+ eosinophil precursor cells; dam-
age occurs to the mucosa, facilitating bacterial penetration
of the mucosa that leads to bacterial infection and further
perpetuates an inflammatory process 
21, 24.
Bacterial infection
Although CRS is not necessarily an infectious condi-
tion, bacteria are often found within the ethmoid and maxil-
lary sinuses 
25. The most common were coagulase-negative
staphylococci (31−56% of isolates), Hemophilus influenzae
(25%),  Staphylococcus aureus (20−39%),  Streptococcus
pneumoniae (9−17%) 
1, 26. Although it is often hypothesized
that CRS evolves from acute rhinosinusitis, this has never
been proven. Furthermore, the role of bacteria in CRS is far
from clear 
26, 27. The presence of intracellular Staphylococcus
aureus in epithelial cells of the nasal and sinus mucosa has
been suggested to pay a significant risk factor for recurrent
episodes of rhinosinusitis due to persistent bacterial clono-
types, which appear to be refractory to antimicrobial and
surgical therapy 
28, 29A recent prospective study revealed that
colonization of the middle meatus with Staphylococcus
aureus is significantly more frequent in CRS with nasal
polyposis (60.3%), compared to CRS without nasal polypo-
sis (27.3%) 
1, 30. Staphylococcus aureus enterotoxins (SAEs)
are able to induce more severe eosinophilic inflammation as
well as the synthesis of a multiclonal IgE response with high
total IgE concentrations in the tissue, which would suggest
that SAEs are at least modifiers of disease in CRS with nasal
polyps 
1, 30. Min et al. 
31  have shown that SAEs have a
ciliostatic effect on the sinus mucosa. Histopathologic find-
ings, induced by SAEs, included severe submucosal edema,
epithelial disruption, and inflammatory cells infiltration
(predominantly neutrophils) 
31.
Helicobacter pylori and laryngopharyngeal reflux
Helicobacter pylori DNA has been detected in between
11 and 33% of sinus samples from the patients with CRS, but
not from the controls. However, this does not prove a causal
relationship 
1, 32.
Conclusions
Chronic rhinosinusitis is a multifactorial problem in-
volving numerous host and non-host factors. The roles of
factors such as allergy, fungal infection and bacterial en-
terotoxins warrant further study. It is clear that these factors
must be taken into account in the diagnosis and long-term
management of CRS.
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